Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 1


Figure 1 Absolute 35-Day Mortality Versus Fibrinolytic Treatment Delay*

*Solid circles = information from trials included in Fibrinolytic Therapy Trialists’ Collaborative Group analysis; open circles = information from additional trials; small squares = data beyond scale of x/y cross. The linear and nonlinear regression lines are fitted within these data, weighted by inverse of the variance of the absolute benefit in each datapoint. Solid squares = average effects in 6 time-to-treatment groups (areas of squares inversely proportional to variance of absolute benefit described). Reproduced with permission from Boersma et al. (28).





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement